¼¼°èÀÇ °¨¿° °ü¸® °¨½Ã ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­(2025³â)
Infection Control Surveillance Solutions Global Market Report 2025
»óǰÄÚµå : 1810919
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,457,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,334,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,211,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°¨¿° °ü¸® °¨½Ã ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 2029³â¿¡´Â CAGR 9.1%·Î 25¾ï 9,000¸¸ ´Þ·¯·Î ¼ºÀåÇÕ´Ï´Ù. ¿¹Ãø ±â°£ Áß ¿¹»óµÇ´Â ¼ºÀåÀº °í·ÉÀÚ ¹× ¸é¿ª °áÇÌ Àα¸ Áõ°¡, ¸ð¹ÙÀÏ ¹× Ŭ¶ó¿ìµå ±â¹Ý °¨¿° Á¦¾î ¸ð´ÏÅ͸µ ½Ã½ºÅÛ(ICSS) Ç÷§ÆûÀÇ »ç¿ë È®´ë, º´¿ø IT ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ È®´ë, ÇコÄɾî ÁöÃâ Áõ°¡, ¿ø°ÝÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µÀÇ È®´ë¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ ±â°£ Áß ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â °¨¿° ÃßÀû ½Ã½ºÅÛÀÇ ÀÚµ¿È­ °­È­, »óÈ£ ¿î¿ë °¡´ÉÇÑ ¸ð´ÏÅ͸µ Ç÷§ÆûÀÇ °³¹ß, ¿þ¾î·¯ºí °¨¿° ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ Çõ½Å, Ŭ¶ó¿ìµå ³×ÀÌÆ¼ºê °¨¿° Á¦¾î ¼Ö·ç¼ÇÀÇ ¹ßÀü, °¨¿° °æÇ⠺м®À» À§ÇÑ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ ±¤¹üÀ§ÇÑ Àü°³ µîÀÌ ÀÖ½À´Ï´Ù.

ÀÇ·á °ü·Ã °¨¿°(HAI) Áõ°¡·Î ÀÎÇØ °¨¿° °ü¸® ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. HAI´Â ȯÀÚ°¡ ÀÇ·á½Ã¼³ ³»¿¡¼­ ÀÇ·á ¹× ¿Ü°úÀû Ä¡·á¸¦ ¹Þ´Â µ¿¾È °¨¿°µÇ´Â °ÍÀÔ´Ï´Ù. HAI Áõ°¡´Â Ä«Å×ÅÍ, ÀΰøÈ£Èí±â µî ħ½ÀÀû ÀÇ·á±â±âÀÇ »ç¿ë Áõ°¡¿Í °ü·ÃÀÌ ÀÖÀ¸¸ç, ÀÌ´Â À¯ÇØÇÑ º´¿ø±ÕÀÌ Ã¼³»·Î À¯À﵃ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. °¨¿°°ü¸® ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀº °¨¿° µ¿ÇâÀ» Á¶±â¿¡ ÆÄ¾ÇÇÏ¿© ¹ß»ýÀ» ¿¹¹æÇϱâ À§ÇÑ Àû½Ã °³ÀÔÀ» Áö¿øÇÔÀ¸·Î½á HAI °¨¼Ò¸¦ µ½½À´Ï´Ù. ¿¹¸¦ µé¾î 2025³â 6¿ù ¿µ±¹¿¡ º»»ç¸¦ µÐ Àú³Î ÃâÆÇ»ç BMC Infectious Diseases°¡ ¹ßÇ¥ÇÑ ³í¹®¿¡ µû¸£¸é º´¿ø³» °¨¿°·üÀº 2021³â ȯÀÚ 1,000¸í´ç 0.98¸í¿¡¼­ 2022³â 1.31¸íÀ¸·Î Áõ°¡ÇÏ¿© º´¿ø³» °¨¿° Áõ°¡°¡ ¹®Á¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌó·³ °¨¿°°ü¸® ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀº HAI ¹ß»ý·ü Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

°¨¿° °ü¸® ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº ¿ø³»°¨¿°(HAI)ÀÇ Á¶±â ¹ß°ß ¹× ´ëÀÀ °³¼±À» ¸ñÇ¥·Î ÇÑ Ã·´Ü °¨¿° ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. °¨¿° ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº ÀÇ·á ȯ°æ³» °¨¿°À» ¸ð´ÏÅ͸µ, ½Äº°, º¸°íÇϰí Àû½Ã¿¡ ¿¹¹æ ¹× °ü¸® Ȱµ¿À» ÃËÁøÇϱâ À§ÇØ ¼³°èµÈ µðÁöÅÐ ¶Ç´Â ¼öµ¿ ÅøÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 11¿ù Penta ETS Àç´ÜÀÌ ÁÖ°üÇÏ´Â À¯·´ ±â¹Ý ½Å»ý¾Æ °¨¿° ¿¹¹æ ±¸»ó NeoIPC´Â ½Å»ý¾Æ ÁßȯÀÚ½Ç(NICU)ÀÇ °¨¿° ¿¹¹æ ³ë·ÂÀ» °­È­Çϱâ À§ÇØ »õ·Î¿î °¨½Ã ÅøÅ°Æ®À» µµÀÔÇß½À´Ï´Ù. ÀÌ ÅøÅ°Æ®Àº ½Å»ý¾Æ ÀÇ·á¿¡ ¸ÂÃá ½Ç½Ã°£ µ¥ÀÌÅÍ ¼öÁýÀ» Á¦°øÇÏ¿© °¨¿° Ŭ·¯½ºÅÍ ¹× Ç×±ÕÁ¦ ³»¼º Ãß¼¼¸¦ Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀÌ ÅøÅ°Æ®¿¡´Â NICU Á÷¿øÀÌ °¨¿° ¿¹¹æ ¹× °ü¸® ÁöÇ¥¸¦ ÃßÀûÇÒ ¼ö ÀÖ´Â ¸ÂÃãÇü ´ë½Ãº¸µå°¡ Æ÷ÇԵǾî ÀÖÀ¸¸ç, ½Å¼ÓÇÑ °³ÀÔÀ» À¯µµÇϱâ À§ÇÑ ÀÇ»ç°áÁ¤ Áö¿ø ¾Ë°í¸®ÁòÀÌ ÅëÇյǾî ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ ÅøÅ°Æ®Àº ½Ã¼³ °£ µ¥ÀÌÅÍ °øÀ¯¿Í º¥Ä¡¸¶Å·À» ÃËÁøÇϰí, °øµ¿ ÇнÀ°ú °¨¿° À§Çè¿¡ ´ëÇÑ ½Å¼ÓÇÑ ´ëÀÀÀ» ÃËÁøÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼ ¹× Covid¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Infection control surveillance solutions encompass systems and technologies designed to monitor, track, and analyze infection trends within healthcare environments to prevent and manage the spread of infectious diseases. These solutions facilitate real-time data collection, reporting, and alerting, enabling healthcare providers to take timely actions and ensure patient safety.

The primary product categories of infection control surveillance solutions include software, hardware, and services. Infection control surveillance software solutions are digital platforms that track, analyze, and notify healthcare professionals about potential healthcare-associated infections (HAIs), supporting prompt intervention and enhancing patient safety. These software solutions are available in various deployment models, such as on-premise, cloud-based, and hybrid systems. They are used across applications including infection control, surveillance and reporting, data management, compliance monitoring, and quality improvement. The main end-users consist of hospitals, long-term care facilities, home healthcare providers, ambulatory surgical centers, and clinical laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The infection control surveillance solutions market research report is one of a series of new reports from The Business Research Company that provides infection control surveillance solutions market statistics, including the infection control surveillance solutions industry global market size, regional shares, competitors with the infection control surveillance solutions market share, detailed infection control surveillance solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the infection control surveillance solutions industry. This infection control surveillance solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The infection control surveillance solutions market size has grown strongly in recent years. It will grow from $1.67 billion in 2024 to $1.83 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth during the historical period can be attributed to increased awareness of hygiene and patient safety, expanded implementation of electronic health records (EHRs), heightened focus on hospital accreditation and compliance, greater adoption of antimicrobial stewardship programs, and enhanced training initiatives for healthcare professionals on infection control.

The infection control surveillance solutions market size is expected to see strong growth in the next few years. It will grow to $2.59 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The projected growth during the forecast period can be attributed to the increasing geriatric and immunocompromised populations, the expanding use of mobile and cloud-based infection control surveillance system (ICSS) platforms, growing investments in hospital IT infrastructure, rising healthcare spending, and the expansion of telehealth and remote monitoring. Key trends expected in this period include enhanced automation in infection tracking systems, development of interoperable surveillance platforms, innovations in wearable infection monitoring devices, advancements in cloud-native infection control solutions, and broader deployment of remote patient monitoring for infection trend analysis.

The increasing occurrence of healthcare-associated infections (HAIs) is expected to drive growth in the infection control surveillance solutions market. HAIs are infections that patients acquire while undergoing medical or surgical treatment within healthcare facilities. The rise in HAIs is linked to the growing use of invasive medical devices such as catheters and ventilators, which can introduce harmful pathogens into the body. Infection control surveillance solutions aid in reducing HAIs by enabling the early identification of infection trends and supporting timely interventions to prevent outbreaks. For example, in June 2025, an article published by BMC Infectious Diseases, a UK-based journal publisher, reported that the rate of hospital-acquired infections increased from 0.98 per 1,000 patient-days in 2021 to 1.31 in 2022, indicating a troubling rise in nosocomial infections. Thus, the growth of the infection control surveillance solutions market is being driven by the rising incidence of HAIs.

Key players in the infection control surveillance solutions market are developing advanced infection surveillance systems aimed at improving early detection and response to HAIs. Infection surveillance systems are digital or manual tools designed to monitor, identify, and report infections within healthcare environments, facilitating timely prevention and control actions. For instance, in November 2023, NeoIPC, a Europe-based neonatal infection prevention initiative coordinated by Fondazione Penta ETS, introduced a new surveillance toolkit to strengthen infection prevention efforts in neonatal intensive care units (NICUs). This toolkit offers real-time data collection tailored to neonatal care, enabling early detection of infection clusters and antimicrobial resistance trends. It includes customizable dashboards for NICU staff to track infection prevention and control indicators and integrates decision-support algorithms to guide prompt interventions. Additionally, the toolkit promotes data sharing and benchmarking between institutions to encourage collaborative learning and quicker responses to infection risks.

In February 2024, Inovalon Holdings Inc., a US-based cloud software provider, acquired VigiLanz Corporation for an undisclosed sum. This acquisition is intended to enhance Inovalon's real-time clinical surveillance, patient safety, and data analytics capabilities across healthcare settings. VigiLanz Corporation is a US company specializing in SaaS-based clinical surveillance and patient safety software and data solutions.

Major players in the infection control surveillance solutions market are Oracle Corporation, 3M Company, Becton Dickinson and Company, Baxter International Inc., Ecolab Inc., Wolters Kluwer N.V., STERIS plc, Getinge AB, Premier Inc., Inovalon Holdings Inc., Belimed AG, Harris Healthcare Solutions Inc., RLDatix Group, Hygiena LLC, CenTrak Inc., Matachana Group S.A., Pal International Ltd., Azalea Health Innovations Inc., TOMI Environmental Solutions Inc., Ocean Health Systems Inc.

North America was the largest region in the infection control surveillance solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in infection control surveillance solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the infection control surveillance solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infection control surveillance solutions market consists of revenues earned by entities by providing services such as antimicrobial stewardship support, performance metrics, cloud hosting, training, and alert and escalation workflows. The market value includes the value of related goods sold by the service provider or included within the service offering. The infection control surveillance solutions market also includes sales of antimicrobial stewardship systems, clinical decision support systems, electronic health record (EHR) integration modules, antibiotic resistance tracking tools, and outbreak detection and alert systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infection Control Surveillance Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infection control surveillance solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for infection control surveillance solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infection control surveillance solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

3) By Services - Installation And Integration Services; Training And Support Services; Consulting Services; Data Analysis And Reporting Services; Managed Services

Table of Contents

1. Executive Summary

2. Infection Control Surveillance Solutions Market Characteristics

3. Infection Control Surveillance Solutions Market Trends And Strategies

4. Infection Control Surveillance Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Infection Control Surveillance Solutions Growth Analysis And Strategic Analysis Framework

6. Infection Control Surveillance Solutions Market Segmentation

7. Infection Control Surveillance Solutions Market Regional And Country Analysis

8. Asia-Pacific Infection Control Surveillance Solutions Market

9. China Infection Control Surveillance Solutions Market

10. India Infection Control Surveillance Solutions Market

11. Japan Infection Control Surveillance Solutions Market

12. Australia Infection Control Surveillance Solutions Market

13. Indonesia Infection Control Surveillance Solutions Market

14. South Korea Infection Control Surveillance Solutions Market

15. Western Europe Infection Control Surveillance Solutions Market

16. UK Infection Control Surveillance Solutions Market

17. Germany Infection Control Surveillance Solutions Market

18. France Infection Control Surveillance Solutions Market

19. Italy Infection Control Surveillance Solutions Market

20. Spain Infection Control Surveillance Solutions Market

21. Eastern Europe Infection Control Surveillance Solutions Market

22. Russia Infection Control Surveillance Solutions Market

23. North America Infection Control Surveillance Solutions Market

24. USA Infection Control Surveillance Solutions Market

25. Canada Infection Control Surveillance Solutions Market

26. South America Infection Control Surveillance Solutions Market

27. Brazil Infection Control Surveillance Solutions Market

28. Middle East Infection Control Surveillance Solutions Market

29. Africa Infection Control Surveillance Solutions Market

30. Infection Control Surveillance Solutions Market Competitive Landscape And Company Profiles

31. Infection Control Surveillance Solutions Market Other Major And Innovative Companies

32. Global Infection Control Surveillance Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infection Control Surveillance Solutions Market

34. Recent Developments In The Infection Control Surveillance Solutions Market

35. Infection Control Surveillance Solutions Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â